Heron Therapeuti (HRTX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.07B
EV to revenue ratio (TTM)
1.20
EV to ebitda
49.68
Financial Performance
Revenue (TTM)
$0.15B
Gross profit (TTM)
$0.09B
EBITDA
-$0.01B
Profitability
Operating margin (TTM)
-4.74%
Profit margin
-14.50%
Return on assets (TTM)
-2.20%
Return on equity (TTM)
-217.80%
Per Share Metrics
Revenue per share (TTM)
$0.78
EPS
-$0.11
Diluted EPS (TTM)
-$0.11
Book value
$0.02
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
46.95
PEG ratio
-0.18
Price to sales ratio (TTM)
0.48
Price to book ratio (TTM)
17.88
Growth
Quarterly earnings growth (YoY)
-7.80%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
n/a
Buy
n/a
Hold
n/a
Sell
n/a
Strong sell
n/a
Risk & Volatility
Beta
1.65